SAN FRANCISCO — In this video exclusive, Elizabeth V. Saarel, MD, FHRS, highlights a low incidence of serious adverse events due to sports participation in young patients with implantable cardioverter defibrillators observed in a study presented at the Heart Rhythm Society Annual Scientific Sessions.
The multinational registry enrolled athletes aged younger than 21 years participating in competitive or dangerous sports. The primary endpoint was death or resuscitated arrest during sports participation or injury during sports due to shock or arrhythmic symptoms. There were no events related to the primary endpoint, according to Saarel.
“This is good news for patients with ICDs who really want to participate in sports due to quality of life,” Saarel said.